Plant Health Care Signs Development & Distribution Agreement With Arysta LifeScience
December 5, 2014 Plant Health Care, a leading provider of novel biological products to global agriculture markets, announces that it has signed a development & distribution agreement with Arysta LifeScience Ltd. for the use of Plant Health Care’s proprietary protein technology for foliar application to sugar cane in Brazil. Commercial terms were not disclosed.
Under this agreement, Arysta LifeScience will evaluate the technology across a range of geographical locations throughout Brazil. The expanded testing program will generate detailed information on increased biomass and sucrose production, which
in earlier studies showed significant and reliable increases in yield.
Pending local registration and consistent, reliable test results in the evaluation program, first sales of the product are anticipated in the 2017 crop season.
Sugarcane is an important crop in Brazil, covering more than 8,000,000 hectares. Much of this cane is used for ethanol production, which is a major pillar in the renewable fuel policy of the Brazilian government.
“We are pleased to enter into this agreement with Arysta LifeScience to bring this proprietary protein technology to such a commercially significant crop in Brazil,” said Paul Schmidt, CEO of Plant Health Care. “This is another step forward in the implementation of Plant Health Care’s dual-track strategy of substantially growing revenue from existing products whilst pursuing an aggressive R&D focus on new technology development.”
“We are excited about the opportunity to expand the organization’s portfolio in sugarcane,” added Paula Pinto, Global Head of Marketing at Arysta LifeScience. “The addition of the proprietary protein technology will provide sugarcane farmers the opportunity to significantly increase yield and sugar production in ratoon cane.”
Subscribe Today For
